Live
- PM Modi’s welfare schemes transform rural lives in Bokaro, residents share gratitude
- We will ensure Bangladeshi infiltrators are removed from Jharkhand: BJP's Gourav Vallabh
- Hezbollah fires five rockets at central, northern Israel: sources
- HM Amit Shah, Rajnath Singh to address several rallies in Jharkhand tomorrow
- Will not waste single day in getting back what we lost, Omar Abdullah tells Assembly
- PM Modi visits Advani's residence to wish him on birthday, shares special moment
- Sun-Dried Cotton to Be Taken to CCI Purchase Centers, Avoid Middlemen - Collector
- Survey Process Requires Public Cooperation - Collector Badavath Santosh
- Distribution of Maize Seeds to Farmers at Agricultural Research Center
- Education with Human Values Must be Provided to Students - Telangana State Higher Education Council Chairman Prof. V. Balakista Reddy
Five more Covid vaccines in pipeline
Five more Covid vaccines in pipeline
Johnson & Johnson, Sputnik V expected by Oct
The Centre is gearing to scale up the Covid-19 vaccine production as more and more States flag shortage of vaccine doses. It is expected that by the end of the third quarter of 2021, India will get five additional vaccine manufacturers apart from current manufactures Covishield and Covaxin.
Around 20 Covid-19 vaccines are in various clinical and pre-clinical stages and will add a boost to India's vaccine production. As per top government sources, the new strategy is to manufacture additional vaccine doses.
"These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's intranasal vaccine," a source was quoted as saying. Sputnik V vaccine is expected to get the Emergency Use Approval (EUA) within the next ten days.
